Pediatrics Doctors in Searcy, AR Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Donald Jeff Moore, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2808    Fax: 501-278-3001

Dr. Benjaman Travis Wilkins, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 400 S Main St, Suite 200, Searcy, AR 72143 Phone: 501-279-0502    Fax: 501-279-0506

James Dale Wilkins, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2800    Fax: 501-268-3946

Edward L Mcadams, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2505 W Beebe Capps Expy, Searcy, AR 72143 Phone: 501-278-2800    Fax: 501-368-0767

Jeter L Stinnett, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2808    Fax: 501-278-3001

Samuel Tucker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2800    Fax: 501-268-3946

Annie T Luy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1407 E Race Ave, Searcy, AR 72143 Phone: 501-279-1472    Fax: 501-268-4385

Dr. Mark Edward Gustke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2800    Fax: 501-268-3946

News Archive

Blood pressure's internal circadian rhythm does not appear to increase morning heart attacks

The internally-driven daily cycle of blood pressure changes doesn't appear to be linked to the known increase in morning heart attacks, according to a study in Circulation Research: Journal of the American Heart Association.

DNA-binding protein acts like genetic traffic signal to orchestrate early stage embryonic development

New research by UC San Francisco stem cell biologists has revealed that a DNA-binding protein called Foxd3 acts like a genetic traffic signal, holding that ball of undifferentiated cells in a state of readiness for its great transformation in the third week of development.

Report highlights benefits of Nuvilex's cell encapsulation technology for diabetes

Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.

Blog examines Japanese contribution to global vaccine efforts

In a post in Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Seth Berkley, CEO of the GAVI Alliance, examines "the contribution the Japanese people have made to immunization."

Read more Medical News

› Verified 3 days ago